8 SAFETY OF TELAPREVIR OR BOCEPREVIR IN COMBINATION WITH PEGINTERFERON ALFA/RIBAVIRIN, IN CIRRHOTIC NON RESPONDERS. FIRST RESULTS OF THE FRENCH EARLY ACCESS PROGRAM (ANRS CO20-CUPIC)

Gastroenterología y Hepatología,2012, 引用: 6

Liver Transplantation,2013, 引用: 7

Nature Reviews Drug Discovery,2013, 引用: 154

British Journal of Clinical Pharmacology,2013, 引用: 40

Clinical Microbiology and Infection,2015, 引用: 11

Orvosi Hetilap,2013, 引用: 0

Orvosi Hetilap,2013, 引用: 0

Hepatology,2013, 引用: 47

Infectious Disease Clinics of North America,2012, 引用: 2

Alimentary Pharmacology & Therapeutics,2013, 引用: 23